Abstract
The synthesis of a novel unsymmetrical dihydropyridine, bearing carboxy methyl and carbomethoxy groups at C(3) and C(5), respectively, has been achieved by applying the modified Hantzsch-type condensation, which involves the Michael addition of Knoevenagel adduct with an enamine. The product obtained was characterized by spectroscopic techniques and finally confirmed by X-ray diffraction studies. The title compound C17H19NO3 crystallizes in Monoclinic crystal class in space group P21/c with cell parameters a = 9.9130(12) Å, b = 7.3320(5) Å, c = 22.018(3) Å, β = 109.637(3)°, V = 1507.2(3) Å3 and Z = 4. The final residual factor R 1 = 0.0642. The structure exhibits both intra and inter-molecular hydrogen bonding of the type C–H···O and N–H···O. The pyridine ring gives boat conformation.
Graphical Abstract
The crystal and molecular structure of 2,6-dimethyl-3-acetyl-5-carbomethoxy-4-phenyl-1,4-dihydropyridine has been determined by X-ray diffraction methods.
Similar content being viewed by others
References
Mayler WG (1989) Calcium antagonist. Academic Press, London
Janis RA, Silver PJ, Triggle DJ (1987) Adv Drug Res 16:309
Bossert F, Vater W (1989) Med Res Rev 9:291
Martı′n N, Seoane C (1990) Quim Ind 36:115
Peri R, Padmanabhan S, Rutledge A, Singh S, Triggle DJ (2000) J Med Chem 43:2906
Tasaka S, Ohmori H, Gomi N, Iino M, Machida T, Kiue A, Naito S, Kuwano M (2001) Bioorg Med Chem Lett 11:275
Harper JL, Camerini-Otero CS, Li A, Kim S, Jacobson KA, Daly JW (2003) Biochem Pharmacol 65:329
Fernandes AAS, Santos MS, Vicente JAF, Moreno AJM, Velena Aa, Duburs G, Oliveira CR (2003) Mitochondrion 3:47
Okamura T, Kikuchi T, Nagamine A, Fukushi K, ekine T, Arano Y, Irie T (2005) Free Radical Biol Med 38:1197
Goldmann S, Stoltefuss J (1991) Angew Chem Int Ed Engl 30:1559
Triggle DJ, Langs DA, Jamis RA (1989) Med Res Rev 9:123
Mehdi S, Ravikumar K (1992) Acta Crystallogr Sect C C48:1627
Rowan KR, Holt ME (1996) Acta Crystallogr Sect C C52:2207
Hemmateenejad B, Miri R, Safarpour MA, Khoshneviszadeh M, Edraki N (2005) J Mol Struct 717:139
Eisner U, Kuthan J (1972) Chem Rev 72:1
Stout DM, Meyers AI (1982) Chem Rev 82:223
Bossert F, Meyer H, Wehinger E (1981) Angew Chem Int Ed Engl 20:762
Kuthan J, Kurfürst A (1982) Ind Eng Chem Prod Res Dev 21:191
Chorvat RJ, Roring KJ (1988) J Org Chem 53:5779
Guzman A, Romero M, Maddox A, Muchowski J (1990) J Org Chem 55:5793
Kappe CO (1993) Tetrahedron 49:6937
Yagupolskii LM, Maletina II, Petko KL, Fedyuk DV, Handrock R, Shavaran SS, Klebanov BM, Herzig S (2001) J Fluorine Chem 109:87
Velázquez C, Knaus EE (2004) Bioorg Med Chem 12:3831–3840
Bossert F, Vater W (1989) Med Res Rev 9:531
Triggle DJ (2003) Mini-Rev Med Chem 3:215
Triggle DJ (2003) Cell Mol Neurobiol 23:293
Murphy KMM, Gould RJ, Largent BL, Synder SH (1983) Proc Natl Acad Sci USA 80:860
Ferry DR, Glossmann H (1982) Naunyn Schmiedeberg’s Arch Pharmacol 321:80
Itil TM, Michael ST, Hoffmeister F, Kunitz A, Eralp E (1984) Curr Ther Res 35:405
Goldmann S, Stolefuss J (1991) Angew Chem Int De Engl 30:1559
Schramm M, Thomas G, Towart R, Franckowiak G (1983) Nature 303:535
Budriesi R, Bisi A, Ioan P, Rampa A, Gobbi S, Bulleti F, Piazzi L, Valenti P, Chiarini A (2005) Bioorg Med Chem 13:3423
Engi He, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, Adlakha P, Shah A, Motohashi N, Ocsovszki I, Molnar J (2006) In vivo 20:637
Naveen S, Prasad SJ, Manvar D, Mishra A, Shah A (2008) J Chem Crystallogr 38(4):315
Fusi F, Saponara S, Valoti M, Dragoni S, D’Elia P, Sgaragli T, Alderighi D, Kawase M, Shah A, Motohashi N, Sgaragli G (2006) Current Drug Targets 7(12):1729
Triggle AM, Shefter E, Triggle DJ (1980) J Med Chem 23:1442
Adlakha P, Naveen S, Lakshmi S, Manvar A, Karia D, Shah A, Sridhar MA, Prasad JS (2006) J Chem Crystallogr 39:389
Saponara S, Kawase M, Shah A, Motohashi N, Molnar J, Ugocsai K, Sgaragli G, Fusi F (2004) Br J Pharmacol 141(3):415
Shah A, Bariwal J, Molnar J, Kawase M, Motohashi N (2007) Topics in heterocyclic chemistry. Springer, Berlin/Heidelberg
D’Elia P, De Matteis F, Dragoni S, Shah A, Sgaragli G, Valoti M (2009) Eur J Pharmacol 614(1–3):7
Venkatesh BD, Hirihally CD, Beeranahally HD, Madegowda M, Shah A, Anandalwar SM, Prasad JS (2004) Anal Sci 20(3):501
Gevariya H, Desai B, Vora V, Shah A (2001) Heterocycl Commun 7(2):167
Otwinowski Z, Minor W (1997) In: Carter CW Jr, Sweet RM (eds) Methods in enzymology: macromolecular crystallography, vol 276. Academic Press, New York, p 307
Mackay S, Gillmore CJ, Edwards C, Shankland K (1999) maXus, Computer program for the solution and refinement of crystal structures. Bruker Nonius, The Netherlands
Sheldrick GM (1997) SHELXS-97. Program for crystal structure solution. University of Göttingen, Germany
Acknowledgments
The authors are thankful for facility & grants given under University Grant Commission, New Delhi-Special Assistance Program; (DRS) Department Research Support (Sanction No. 540/6/DRS/2004, SAP-I, Dt. 26/03/2004), Department of Science and Technology, New Delhi Fund for Improvement of Science and Technology (FIST, sanction No. SR/FST/CSI-072/2003, Dt. 24/12/2003) and National facility for drug discovery through new chemical entities development and instrumentation support to small manufacturing pharma enterprises under DPRP project (Sanction No.VI-D&P/188/06-07/TDT, Dt. 30/03/07), Industries commissionerate, Government of Gujarat, Gandhinagar and also facility given by Department of Chemistry, Saurashtra University, Rajkot-360 005(INDIA) & to Amit Trivedi for UGC Meritorious fellowship by University Grant Commission, New Delhi.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trivedi, A., Gowda, N.S., Naliapara, Y. et al. Synthesis, Characterization, Crystal and Molecular Structure Analysis of 2,6-Dimethyl-3-Acetyl-5-Carbomethoxy-4-Phenyl-1,4-Dihydropyridine. J Chem Crystallogr 41, 774–778 (2011). https://doi.org/10.1007/s10870-010-9972-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10870-010-9972-7